Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-12-05

FDA Approved: OLOPATADINE HYDROCHLORIDE — Original Application (Bausch & Lomb Incorporated)

View source ↗

Summary

FDA approved the original application for olopatadine hydrochloride ophthalmic solution from Bausch & Lomb. This antihistamine eye drop is indicated for allergi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLOPATADINE HYDROCHLORIDE OPHTHALMIC SOLUTION (olopatadine hydrochloride ophthalmic solution)

Snippet

ORIG AP for OLOPATADINE HYDROCHLORIDE (OLOPATADINE HYDROCHLORIDE)